ScoreWhy is Sinotherapeutics, Inc. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 21.04% and Operating profit at 41.41% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 10.64% signifying low profitability per unit of shareholders funds
2
With a fall in EPS of -19.86%, the company declared Very Negative results in Mar 25
- DEBT-EQUITY RATIO (HY) Highest at -56.7 %
- NET SALES(Q) At CNY 108.07 MM has Fallen at -15.06%
- RAW MATERIAL COST(Y) Grown by 6.61% (YoY)
3
Below par performance in long term as well as near term
- Along with generating -5.88% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sinotherapeutics, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sinotherapeutics, Inc.
-4.92%
0.55
38.18%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
21.04%
EBIT Growth (5y)
41.41%
EBIT to Interest (avg)
54.21
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.30
Tax Ratio
9.90%
Dividend Payout Ratio
21.80%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.52%
ROE (avg)
10.64%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
3.69
EV to EBIT
36.19
EV to EBITDA
29.04
EV to Capital Employed
7.28
EV to Sales
7.96
PEG Ratio
1.40
Dividend Yield
NA
ROCE (Latest)
20.11%
ROE (Latest)
9.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
INTEREST COVERAGE RATIO(Q)
Highest at 12,676,551.98
OPERATING CASH FLOW(Y)
Highest at CNY 177.51 MM
NET SALES(HY)
At CNY 256.36 MM has Grown at 31.52%
ROCE(HY)
Highest at 10.05%
NET PROFIT(9M)
Higher at CNY 94.04 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 6.17%
-12What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -56.7 %
NET SALES(Q)
At CNY 108.07 MM has Fallen at -15.06%
RAW MATERIAL COST(Y)
Grown by 6.61% (YoY
OPERATING PROFIT(Q)
Lowest at CNY 20.89 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 19.33 %
PRE-TAX PROFIT(Q)
Lowest at CNY 23.18 MM
NET PROFIT(Q)
Lowest at CNY 20.49 MM
EPS(Q)
Lowest at CNY 0.05
Here's what is working for Sinotherapeutics, Inc.
Interest Coverage Ratio
Highest at 12,676,551.98 and Grown
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Cash Flow
Highest at CNY 177.51 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Highest at 6.17%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Sinotherapeutics, Inc.
Net Sales
At CNY 108.07 MM has Fallen at -15.06%
over average net sales of the previous four periods of CNY 127.23 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Debt-Equity Ratio
Highest at -56.7 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 20.89 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 19.33 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 23.18 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 23.18 MM has Fallen at -34.48%
over average net sales of the previous four periods of CNY 35.38 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 20.49 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Net Profit
At CNY 20.49 MM has Fallen at -35.82%
over average net sales of the previous four periods of CNY 31.93 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.05
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Raw Material Cost
Grown by 6.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
